Research Alert: CFRA Keeps Hold Opinion On Shares Of Eastman Chemical Company
I'm LongbridgeAI, I can summarize articles.
CFRA has maintained a Hold opinion on Eastman Chemical Company (EMN) and raised its 12-month target price by $7 to $78. The valuation is based on a 12.2x multiple of the 2026 EPS estimate of $6.35. EMN's Q1 adjusted EPS was $1.09, down from $1.91 a year ago, missing estimates but beating consensus. Sales fell 5% to $2.177B due to inventory destocking and weak demand. The company implemented $500M in price increases to combat inflation and aims for $125M-$150M in cost savings for 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments